Sarah L. Anderson, PharmD (she/her)

Pharmacist 👩🏼‍⚕️ | Educator 👩🏼‍🏫 | Writer 📝 | Clinical Researcher 🩺 | Colorado Native 🏔 | Slow Runner 🏃🏼‍♀️| she/her | Views & posts are my own

[Sarah L. Anderson, PharmD (she/her) @sandersonrx]

Join us on Tuesday, June 16th, for this exciting webinar from @PeerView on practical use of new and emerging ART for people with #HIV https://t.co/CjxM5cy2rt

#MedEd #HIVcare #shareddecisionmaking

[PeerView @PeerView]

Great discussion and valuable insights from Drs. Goldman, Camidge (@DRCamidge), and Le (@LeXiuning) during #ASCO26 on Saturday!

📺 Watch the replay on demand: https://t.co/hjMuooDcVD

Thanks to @AbbVie for support and @LUNGevity for collaboration. #CME #Oncology #MedEd

[PeerView @PeerView]

#CART therapy is transforming #lymphoma care! Pharmacists play a critical role in education, care coordination, safety management, and post-treatment monitoring throughout the CAR-T journey. Watch this #MedEd activity today to learn more: https://t.co/0XlwnbLK4H

[PeerView @PeerView]

Appreciation to @LealTiciana, @BenCreelan, and @JuliaRotow for a thoughtful and impactful session at #ASCO26 on Saturday! Replay available here: https://t.co/0FPsXaaA3g

Thank you to @AstraZeneca, @Regeneron, and @SMMT_TX for grant support & @LUNGevity for collaboration. #CME #MedEd

[PeerView @PeerView]

Great discussion and valuable insights from Drs. Leighl, Jänne and Sabari (@JSabari) during #ASCO26 on Saturday!

📺 Watch the replay on demand: https://t.co/W9BIMWXwFJ

Thanks to @AstraZeneca, @JNJNews, and Black Diamond Therapeutics for support & @LUNGevity for collaboration. #CME #Oncology #MedEd

[PeerView @PeerView]

Thank you to Drs. Tawbi (@HTawbi_MD), Gibney, and McKean (@MeredithMcKean) for an engaging discussion at #ASCO26 on Saturday!

📺 Missed it? Watch the replay: https://t.co/8HwEy8CdsQ

Appreciation to @bmsnews & @Merck for grant support #CME #MedEd

[PeerView @PeerView]

Join Drs. Cramer, Follows, and Woyach on 6/13 at 9:45 AM CEST during #EHA2026 for a #CLL #MedEd event. Produced with @HealthTree. https://t.co/GPRCd1U5ML #HemOnc

[PeerView @PeerView]

Early diagnosis is crucial in #ATTR. Drs. Julie L. Rosenthal (@JLRosenthal) and Ronald Witteles (@Ron_Witteles) share practical guidance on how internists can recognize red flags and accelerate treatment initiation in appropriate patients: https://t.co/9AmkMTfShm #IM2026 #MedEd

[PeerView @PeerView]

Join Drs. Christie M. Ballantyne (@CBallantyneMD) & Jessica M. Peña on 6/11 @ 7:00 PM CDT during #NLASessions for a #LipidManagement & #ASCVD #MedEd event ➡️ https://t.co/50bPBqq3NB #cardiology #lipidology #endocrinology #InternalMedicine

[PeerView @PeerView]

Empower your practice with the latest in RSV prevention. Learn how maternal vaccination & infant mAbs are reshaping preventative care with Asuncion Mejias, MD, PhD (@megias71) & Flor M. Muñoz, MD: https://t.co/jFTSS2ASjf
#InfectiousDiseases #RSV #NPsforKids

[PeerView @PeerView]

How can nurses strengthen their approach to recognizing and managing transthyretin cardiac amyloidosis? 🫀

Dr. Faizi Jamal invites you to join him, Jill Stratford Waldron (@JillSWaldron), and Dr. Gallegos-Kattán for a symposium on identifying ATTR-CA, reviewing the latest targeted therapy evidence, and optimizing nurse-led patient care.

Join us live or virtually on June 24 at 8:00 AM PDT: https://t.co/oB85JN37DB #AAHFN26 📚

[Jen Silverman @SpeakJen]

⚠️ LDL-C goals still unmet?

Join @PeerView for dinner at #NLA2026 on 06.11 for practical strategies on personalized lipid management, #PCSK9 inhibitors, and improving outcomes in high-risk #ASCVD.

Featuring Drs. @CBallantyneMD & Jessica Peña.

🔗 https://t.co/W9QfXayOtA #MedEd

[PeerView @PeerView]

Hear what the experts are saying about new developments with immunotherapy in melanoma!

At #ASCO26, Hussein Tawbi, MD, PhD, discussed long-term outcomes with PD-1/LAG-3 combinations in metastatic melanoma and new evidence with intismeran autogene + pembrolizumab in the adjuvant setting during a recent interview with Carmine DeLuca, PeerView’s Chief Medical Officer.

Missed PeerView’s melanoma symposium led by Dr. Tawbi or our programs at ASCO? Watch the rebroadcasts and explore how emerging science is advancing the practice of cancer care: https://t.co/jiqPOdqiMA

Check out the full video on our YouTube: https://t.co/IYqPQxif7a

[PeerView @PeerView]

How are emerging bispecifics shaping the future of #AcuteLymphoblasticLeukemia care? Hear insights from Ibrahim Aldoss, MD, and Bijal Shah, MD, in this interactive virtual #CME experience focused on innovation, sequencing, and safety management: https://t.co/gu2Bk61t1x

[PeerView @PeerView]

Case discussions bring #MDD management to life: a 36-year-old man with persistent symptoms and a 45-year-old woman with rising anxiety. Translate evidence into practice with measurement-based care, novel options & key take-home points: https://t.co/muxYpLFGMF @DrVegaUnleashed

[Jen Silverman @SpeakJen]

🎮❤️ #ATTRCA Challenge Accepted?

Join @PeerView at #AAHFN26 for a Game Show–style challenge on diagnosis, targeted therapies, and nursing best practices.

🏆 Compete with peers. Learn from experts.

📅 June 24 | 8:00 AM PDT
🔗 https://t.co/7ab5xWwJAJ #MedEd

[PeerView @PeerView]

#Shingles prevention starts with identification. Using EHR-based clinical decision support can help pinpoint high-risk adults—especially those who are immunocompromised. Smarter systems = better outcomes ➡️ https://t.co/4GmF5WCuHG

[PeerView @PeerView]

Join Jill Stratford Waldron, APRN, GNP-BC (@JillSWaldron), and Cesia Gallegos-Kattán, MD, MHS, FASNC, on 6/24 at 8:00 AM PDT for an #ATTRCA #MedEd event: https://t.co/vIqm3ivdTM #CardioNurse #AAHFN26

[PeerView @PeerView]

Practical Approaches in #HIV Care: Learn how to apply new clinical data to real-world scenario, with @EileenScully9 on June 16 at 7:00 PM EDT. Register: https://t.co/hG2JSGcsV9 #InfectiousDisease

[PeerView @PeerView]

“Long-Term #CLL Treatment: Aligning Patient Priorities With Initiating & Sequencing Targeted Therapy” with Drs. Cramer, Follows, and Woyach on 6/13 at 9:45 AM CEST. Produced with @HealthTree ➡️ https://t.co/GPRCd1U5ML #EHA2026 #HemOnc